SAN DIEGO, June 12 /PRNewswire/ -- Proprius Pharmaceuticals, Inc. today announced that David W. Anderson, Ph.D. has joined the company in the role of Chief Scientific Officer. Dr. Anderson is a seasoned executive with 25 years of experience identifying and pursuing innovative approaches to drug discovery and clinical development. Dr. Anderson has previously held a variety of key management positions, including Chief Scientific Officer at Celgene Corporation/Signal Research Division, Senior Vice President of Research & Development at Signal Pharmaceuticals, Senior Director of Drug Discovery and Experimental Therapeutics at Johnson & Johnson (J&J), Director of the J&J Labs at Scripps Research Institute, and Group Leader at Monsanto/GD Searle.
